Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SLC6A1-NDD Prospective Longitudinal Natural History Study

NCT07531511 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT07531511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07531511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SLC6A1-NDD Prospective Longitudinal Natural History Study
Lead sponsor
UCB Biopharma SRL
Phase
Observational
Overall status
Recruiting
Start date
July 21, 2026
Completion date
May 25, 2029
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

developmental and epileptic encephalopathies (dee), slc6a1 neurodevelopmental disorder (ndd)